<p><img src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2026/03/PT-13-03-2026-shutterstock_2557731283-430x241.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="430" height="241" original-src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2026/03/PT-13-03-2026-shutterstock_2557731283-430x241.jpg"/></p>
<p>公用规模的量子计算机预计将能够以高效的方式实现化学精确的分子模拟。图片来源：Gorodenkoff / Shutterstock.com。</p>
<p>PsiQuantum 与日本国立癌症中心签署了合作研究协议，以推动公用规模量子计算在药物发现和肿瘤学领域的进展。</p>
<p>该合作旨在研究如何在医疗价值链中实施量子计算解决方案，重点关注资源分配、研发和癌症护理中的患者结果。</p>
<h3>深入了解 GlobalData</h3>
<ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
<p>报告</p>
<h4>LOA 和 PTSR 模型 - CDK-002 在头颈癌鳞状细胞中的应用...</h4>
<ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
<p>报告</p>
<h4>LOA 和 PTSR 模型 - CDK-002 在三阴性乳腺癌（TNBC）中的应用</h4>
<h5>深入了解 GlobalData</h5>
<p>商业智能的黄金标准。</p>
<p>了解更多</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/assets/images/GMS-logo.svg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/assets/images/GMS-logo.svg"/></p>
<h4>发现高效的 B2B 营销</h4>
<p>结合商业智能和编辑卓越，覆盖 36 个领先媒体平台的专业人士。</p>
<p>了解更多</p>
<p>在此次合作中，PsiQuantum 将与日本国立癌症中心合作，进一步开发容错量子算法，并共同开发临床相关的量子应用。</p>
<p>该计划还涉及其他日本制药公司。PsiQuantum 的软件套件 Construct 将在合作期间使用。</p>
<p>Construct 是一个安全的平台，旨在设计、分析和优化容错量子计算的算法。</p>
<p>公用规模的量子计算机预计将以更高的效率实现化学精确的分子模拟。这一进展可能加速药物发现过程，降低研究成本，并解决现实世界的医疗挑战。</p>
<p><img src="/wp-content/themes/goodlife-wp-B2B/assets/images/strategic-int.png" alt="" original-src="/wp-content/themes/goodlife-wp-B2B/assets/images/strategic-int.png"/></p>
<p>GlobalData 战略情报</p>
<h1>美国关税正在变化 - 你会反应还是预见？</h1>
<p>不要让政策变化让你措手不及。通过实时数据和专家分析保持主动。</p>
<p>来自 GlobalData</p>
<p>了解更多关于战略情报</p>
<p>PsiQuantum 量子应用副总裁 Sam Pallister 表示：“PsiQuantum 很自豪能与日本国立癌症中心合作，探索公用规模量子计算在设计新治疗方案方面能够带来的益处，造福研究人员和患者。</p>
<p>“一旦部署，公用规模的量子计算机将加速研究和开发，改变我们开发新药物的方式——这样的合作对于确保提供者能够充分利用这一技术至关重要。”</p>
<p>日本国立癌症中心医院东部的全球肿瘤学主任高幸义博士表示：“我们很高兴与 PsiQuantum 合作，利用量子计算技术解决医疗领域的一些最紧迫的挑战。</p>
<p>“我们的团队将共同开展创新研究，解锁制药、生物技术和量子计算交汇处的新解决方案。”</p>

<p>PsiQuantum 已与日本国立癌症中心建立合作关系，以推动药物发现和肿瘤学领域的实用规模量子计算。该合作旨在在医疗保健中实施量子解决方案，重点关注资源分配和患者结果。PsiQuantum 将开发容错量子算法和临床相关应用，利用其软件套件 Construct。预计这一合作将增强分子模拟，加速药物发现，并解决医疗保健挑战，同时获得日本其他制药公司的支持</p>

<p><img src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2026/03/PT-13-03-2026-shutterstock_2557731283-430x241.jpg" alt="" original-src="https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2026/03/PT-13-03-2026-shutterstock_2557731283-430x241.jpg"/></p>
<p>Utility-scale quantum computers are expected to enable chemically accurate molecular simulations with efficiency. Credit: Gorodenkoff / Shutterstock.com.</p>
<div class="lb-trans"><p>公用规模的量子计算机预计将能够以高效的方式实现化学精确的分子模拟。图片来源：Gorodenkoff / Shutterstock.com。</p>
</div><p>PsiQuantum and the National Cancer Center Japan have entered a collaborative research agreement to drive advancements in utility-scale quantum computing within drug discovery and oncology.</p>
<div class="lb-trans"><p>PsiQuantum 与日本国立癌症中心签署了合作研究协议，以推动公用规模量子计算在药物发现和肿瘤学领域的进展。</p>
</div><p>The partnership aims to investigate ways to implement quantum computing solutions throughout the healthcare value chain, with a focus on resource allocation, research and development, and patient outcomes in cancer care.</p>
<div class="lb-trans"><p>该合作旨在研究如何在医疗价值链中实施量子计算解决方案，重点关注资源分配、研发和癌症护理中的患者结果。</p>
</div><h3>Go deeper with GlobalData</h3>
<div class="lb-trans"><h3>深入了解 GlobalData</h3>
</div><ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
<div class="lb-trans"><ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
</div><p>Reports</p>
<div class="lb-trans"><p>报告</p>
</div><h4>LOA and PTSR Model - CDK-002 in Head And Neck Cancer Squamous Cell ...</h4>
<div class="lb-trans"><h4>LOA 和 PTSR 模型 - CDK-002 在头颈癌鳞状细胞中的应用...</h4>
</div><ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
<div class="lb-trans"><ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
</div><p>Reports</p>
<div class="lb-trans"><p>报告</p>
</div><h4>LOA and PTSR Model - CDK-002 in Triple-Negative Breast Cancer (TNBC)</h4>
<div class="lb-trans"><h4>LOA 和 PTSR 模型 - CDK-002 在三阴性乳腺癌（TNBC）中的应用</h4>
</div><h5>Go deeper with GlobalData</h5>
<div class="lb-trans"><h5>深入了解 GlobalData</h5>
</div><p>The gold standard of business intelligence.</p>
<div class="lb-trans"><p>商业智能的黄金标准。</p>
</div><p>Find out more</p>
<div class="lb-trans"><p>了解更多</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/assets/images/GMS-logo.svg" alt="" original-src="https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/assets/images/GMS-logo.svg"/></p>
<h4>Discover B2B Marketing That Performs</h4>
<div class="lb-trans"><h4>发现高效的 B2B 营销</h4>
</div><p>Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.</p>
<div class="lb-trans"><p>结合商业智能和编辑卓越，覆盖 36 个领先媒体平台的专业人士。</p>
</div><p>Find out more</p>
<div class="lb-trans"><p>了解更多</p>
</div><p>Within this collaboration, PsiQuantum will work with the National Cancer Center Japan to further fault-tolerant quantum algorithm development, as well as jointly develop clinically relevant quantum applications.</p>
<div class="lb-trans"><p>在此次合作中，PsiQuantum 将与日本国立癌症中心合作，进一步开发容错量子算法，并共同开发临床相关的量子应用。</p>
</div><p>The initiative also involves other pharmaceutical companies in Japan. PsiQuantum’s software suite, Construct, will be used during the partnership.</p>
<div class="lb-trans"><p>该计划还涉及其他日本制药公司。PsiQuantum 的软件套件 Construct 将在合作期间使用。</p>
</div><p>Construct is a secure platform built for designing, analysing, and optimising algorithms for fault-tolerant quantum computing.</p>
<div class="lb-trans"><p>Construct 是一个安全的平台，旨在设计、分析和优化容错量子计算的算法。</p>
</div><p>Utility-scale quantum computers are expected to enable chemically accurate molecular simulations with greater efficiency. This advancement could accelerate drug discovery processes, reduce research costs, and address real-world healthcare challenges.</p>
<div class="lb-trans"><p>公用规模的量子计算机预计将以更高的效率实现化学精确的分子模拟。这一进展可能加速药物发现过程，降低研究成本，并解决现实世界的医疗挑战。</p>
</div><p><img src="/wp-content/themes/goodlife-wp-B2B/assets/images/strategic-int.png" alt="" original-src="/wp-content/themes/goodlife-wp-B2B/assets/images/strategic-int.png"/></p>
<p>GlobalData Strategic Intelligence</p>
<div class="lb-trans"><p>GlobalData 战略情报</p>
</div><h1>US Tariffs are shifting - will you react or anticipate?</h1>
<div class="lb-trans"><h1>美国关税正在变化 - 你会反应还是预见？</h1>
</div><p>Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.</p>
<div class="lb-trans"><p>不要让政策变化让你措手不及。通过实时数据和专家分析保持主动。</p>
</div><p>By GlobalData</p>
<div class="lb-trans"><p>来自 GlobalData</p>
</div><p>Learn more about Strategic Intelligence</p>
<div class="lb-trans"><p>了解更多关于战略情报</p>
</div><p>PsiQuantum quantum applications vice-president Sam Pallister said: “PsiQuantum is proud to work alongside the National Cancer Center Japan as we explore what utility-scale quantum computing will be able to deliver in designing new treatments for the benefit of researchers and patients.</p>
<div class="lb-trans"><p>PsiQuantum 量子应用副总裁 Sam Pallister 表示：“PsiQuantum 很自豪能与日本国立癌症中心合作，探索公用规模量子计算在设计新治疗方案方面能够带来的益处，造福研究人员和患者。</p>
</div><p>“Once deployed, utility-scale quantum computers will accelerate research and development that transforms how we develop new medicines—and partnerships like these are critical for making sure providers are equipped to take full advantage of this technology.”</p>
<div class="lb-trans"><p>“一旦部署，公用规模的量子计算机将加速研究和开发，改变我们开发新药物的方式——这样的合作对于确保提供者能够充分利用这一技术至关重要。”</p>
</div><p>National Cancer Center Hospital East’s global oncology director Dr Takayuki Yoshino said: “We are thrilled to partner with PsiQuantum on leveraging quantum computing technology to address some of the most pressing challenges in healthcare.</p>
<div class="lb-trans"><p>日本国立癌症中心医院东部的全球肿瘤学主任高幸义博士表示：“我们很高兴与 PsiQuantum 合作，利用量子计算技术解决医疗领域的一些最紧迫的挑战。</p>
</div><p>“Together, our teams are poised to conduct innovative research and unlock new solutions at the intersection of pharmaceuticals, biotechnology, and quantum computing.”</p>
<div class="lb-trans"><p>“我们的团队将共同开展创新研究，解锁制药、生物技术和量子计算交汇处的新解决方案。”</p>
</div>

PsiQuantum 与日本国家癌症中心合作开展量子计算